SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckins Mubadala-backed investment and potential Gulf expansion are driving discussion, with traders viewing the sovereign funds involvement as a sign of institutional support and a possible step toward broader international growth. That optimism is tempered by frustration over the stocks weak, range-bound trading and speculation about buybacks and a future U.S. relisting, for which no timeline is established.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrows selloff is drawing attention amid investor frustration with repeated revenue and guidance misses, management execution, and uncertainty over VEVYEs ability to turn prescription growth into revenue. Long-term bulls still see potential in the expanding ophthalmology portfolio, but skeptics say the company needs to rebuild credibility with consistent results.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ousters Rev8 lidar is drawing attention as partners integrate it into autonomous applications, including wildfire-response drones, aerial mapping, and driverless orchard equipmentsupporting the communitys broader growth thesis around robotics and infrastructure sensing. Traders are bullish on expanding real-world use cases, but some remain frustrated by volatile trading and question how quickly deployments can scale.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivaxs sharp pullback and the absence of a confirmed takeover dominate discussion, with traders split between expecting a Big Pharma bid and viewing the stock as potentially stalled while the company advances obefazimod toward an ulcerative-colitis filing and Crohns data. A French filing reportedly showing Helikon increased its stake also drew attention, but takeover speculation remains unconfirmed.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axons proposed $1 billion offering of zero-coupon convertible notes has fueled concern about potential dilution and contributed to a sharp selloff. Traders are split between viewing the financing as a shareholder risk and seeing it as low-cost growth capital, with the stocks volatile rebound drawing further attention.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

A DEA administrative-law pause in the broader cannabis rescheduling process, prompted by questions about federal review procedures, has driven debate and volatility in cannabis stocks. Traders disagree over whether the pause is a temporary procedural delay or a setback to Schedule III and related tax relief; some see Trulieves medical-cannabis exposure as cushioning the impact, while others note it sold off with the sector.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injectives RWA and institutional-finance expansionincluding tokenized assets and its SEC transfer-agent statusis drawing attention alongside discussion of buybacks and a proposed supply-squeeze change that could increase INJs deflation rate if approved. Bulls view these developments as support for a recovery, while skeptics point to the tokens prolonged weakness and question whether the adoption will translate into demand.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

A modest rebound in Chinese internet stocks has revived discussion of a possible oversold bounce and rotation into China tech, with traders pointing to support and bullish options activity. Others argue the ETF remains in a broader downtrend, citing China-market weakness, policy risks, and persistent underperformance; no single confirmed catalyst dominates.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflares strong earnings and raised outlook, alongside optimism about its AI-agent and cybersecurity infrastructure, are supporting a momentum and new-highs conversation. Bulls point to growth potential and analyst optimism, while skeptics argue the valuation is stretched and warn of a pullback.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

Hyperliquids fee-funded token buybacks and burns are a key bullish theme, with traders also focused on HYPEs recent rally and tests of record highs. Sentiment is divided between dip-buyers expecting the uptrend to continue and traders warning of a pullback amid token-supply concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Brief India: Asian Equities: Strong Step-Up in Earnings Environment. 24 Market-Sectors Show Robust EPS Upgrades and more

In this briefing: Asian Equities: Strong Step-Up in Earnings Environment. 24 Market-Sectors Show Robust EPS Upgrades Eureka Forbes (Initiating Coverage): Turning Strategic Vision into Sustainable Growth. BUY Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 Primer: Wim Plast Ltd (WMP IN) - Nov 2025 Primer: Advanced Enzyme Technologies (ADVENZY IN) - Nov 2025 1. Asian Equities: Strong Step-Up in Earnings Environment. 24 Market-Sectors Show Robust EPS Upgrades Breadth of Asian market-sectors with robust earnings estimate upgrades improved remarkably. We spot 24 with upgrades over the past 1-month, 3-months and 6-months. Couple of weeks ago there were 18. The new sectors that joined the list from our previous study are Chinese technology services, Korean utilities, Indian energy, Malaysian consumer durables and financials and Philippines basic materials. Across Asia, basic materials, financials and electronic technology are prominent earnings gainers. They are driving upgrades in the US also.

Brief India: Eureka Forbes (Initiating Coverage): Turning Strategic Vision into Sustainable Growth. BUY and more

In this briefing: Eureka Forbes (Initiating Coverage): Turning Strategic Vision into Sustainable Growth. BUY Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 Primer: Wim Plast Ltd (WMP IN) - Nov 2025 Primer: Advanced Enzyme Technologies (ADVENZY IN) - Nov 2025 Bharti Airtel Block - Third Selldown by Promoter Entity This Year 1. Eureka Forbes (Initiating Coverage): Turning Strategic Vision into Sustainable Growth. BUY We are initiating coverage of Eureka Forbes Ltd with a BUY rating and a target price of INR 830 per share, valuing the stock at 45x Mar-28E AEPS (excluding intangible amortization and 50% of performance-linked ESOP costs) Our positive view stems from Eureka’s strong market leadership in highly underpenetrated categories, its high brand equity, capable management team, and asset-light business model The company has undergone a major turnaround under new management following Eureka’s acquisition by Advent International, with notable improvements in both growth and margins.

Brief Equities Bottom-Up: Tesla Stock Collapse: The AI Trade That Backfired! and more

In this briefing: Tesla Stock Collapse: The AI Trade That Backfired! BlackRock American Income Trust — Innovative value-based US equity strategy Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 Primer: Wim Plast Ltd (WMP IN) - Nov 2025 Primer: Advanced Enzyme Technologies (ADVENZY IN) - Nov 2025 1. Tesla Stock Collapse: The AI Trade That Backfired! Tesla’s latest earnings and strategic updates present a revealing picture of a company navigating an increasingly complex path. The electric vehicle and clean energy giant is caught between near-term financial pressure and long-term ambitions rooted in AI, autonomy, and robotics. While recent quarterly results missed Wall Street’s expectations—adjusted earnings came in at 40 cents per share and revenue dropped 12% year-over-year to $22.5 billion—investor focus has shifted beyond EV sales. 2. BlackRock American Income Trust — Innovative value-based US equity strategy BlackRock American Income Trust (BRAI) underwent a unique change in strategy on 17 April 2025 following overwhelming shareholder approval.

Brief Growth Ideas: BlackRock American Income Trust — Innovative value-based US equity strategy and more

In this briefing: BlackRock American Income Trust — Innovative value-based US equity strategy Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 Primer: Wim Plast Ltd (WMP IN) - Nov 2025 Primer: Advanced Enzyme Technologies (ADVENZY IN) - Nov 2025 Primer: Mars Group Holdings (6419 JP) - Nov 2025 1. BlackRock American Income Trust — Innovative value-based US equity strategy BlackRock American Income Trust (BRAI) underwent a unique change in strategy on 17 April 2025 following overwhelming shareholder approval. This development was triggered by the board’s desire for improved performance, lower cost and greater scale. Management of the trust shifted from BlackRock’s US Income and Value team to its Systematic Active Equity (SAE) team. BRAI is the first investment trust to employ a systematic investment approach and given the prevalence of growth funds, the company is differentiated by a focus on value and income. Along with the strategy change, there were other enhancements to the trust, including an increased dividend, a fee reduction and opportunities for shareholders to exit at close to NAV; there is a periodic 100% tender offer if three-year performance or minimum fund size targets are not met. 2.

Brief Equities Bottom-Up: BlackRock American Income Trust — Innovative value-based US equity strategy and more

Brief India: Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 and more

In this briefing: Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 Primer: Wim Plast Ltd (WMP IN) - Nov 2025 Primer: Advanced Enzyme Technologies (ADVENZY IN) - Nov 2025 Bharti Airtel Block - Third Selldown by Promoter Entity This Year Tracking the AI Cycle : A Macro View 1. Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 Bombay Burmah Trading Corporation (BBTC) is a diversified holding company of the Wadia Group, with its intrinsic value primarily derived from its ~50.5% stake in the fast-moving consumer goods (FMCG) major, Britannia Industries. The company trades at a significant and persistent discount to the market value of its underlying assets, offering potential for substantial value unlocking. However, this discount is perpetuated by the underperformance of its standalone businesses and concerns over capital allocation. BBTC's standalone operations, mainly in tea plantations and auto-electric components, face industry-specific headwinds and have historically yielded modest returns, weighing on the consolidated financial performance and investor sentiment.

Brief Growth Ideas: Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 and more

In this briefing: Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 Primer: Wim Plast Ltd (WMP IN) - Nov 2025 Primer: Advanced Enzyme Technologies (ADVENZY IN) - Nov 2025 Primer: Mars Group Holdings (6419 JP) - Nov 2025 Sold Out Yet Stockpiled: Nvidia’s Q3 Highlights Potential Deployment Limits 1. Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 Bombay Burmah Trading Corporation (BBTC) is a diversified holding company of the Wadia Group, with its intrinsic value primarily derived from its ~50.5% stake in the fast-moving consumer goods (FMCG) major, Britannia Industries. The company trades at a significant and persistent discount to the market value of its underlying assets, offering potential for substantial value unlocking. However, this discount is perpetuated by the underperformance of its standalone businesses and concerns over capital allocation. BBTC's standalone operations, mainly in tea plantations and auto-electric components, face industry-specific headwinds and have historically yielded modest returns, weighing on the consolidated financial performance and investor sentiment.

Brief Equities Bottom-Up: Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 and more

In this briefing: Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 Primer: Wim Plast Ltd (WMP IN) - Nov 2025 Primer: Advanced Enzyme Technologies (ADVENZY IN) - Nov 2025 Primer: Mars Group Holdings (6419 JP) - Nov 2025 Quantum Data Energy (MAST.L) Rapid Progress 25112025 1. Primer: Bombay Burmah Trading (BBTC IN) - Nov 2025 Bombay Burmah Trading Corporation (BBTC) is a diversified holding company of the Wadia Group, with its intrinsic value primarily derived from its ~50.5% stake in the fast-moving consumer goods (FMCG) major, Britannia Industries. The company trades at a significant and persistent discount to the market value of its underlying assets, offering potential for substantial value unlocking. However, this discount is perpetuated by the underperformance of its standalone businesses and concerns over capital allocation. BBTC's standalone operations, mainly in tea plantations and auto-electric components, face industry-specific headwinds and have historically yielded modest returns, weighing on the consolidated financial performance and investor sentiment.

Brief Equities Bottom-Up: Primer: Wim Plast Ltd (WMP IN) - Nov 2025 and more

In this briefing: Primer: Wim Plast Ltd (WMP IN) - Nov 2025 Primer: Advanced Enzyme Technologies (ADVENZY IN) - Nov 2025 Primer: Mars Group Holdings (6419 JP) - Nov 2025 Quantum Data Energy (MAST.L) Rapid Progress 25112025 DWS: Uncorking Value through Channel Expansion 1. Primer: Wim Plast Ltd (WMP IN) - Nov 2025 Strong Brand Equity and Distribution Network: Wim Plast leverages the widely recognized "Cello"brand, a household name in India for decades, coupled with a robust pan-India network of manufacturing units and depots, providing a significant competitive advantage. Attractive Valuation with Consistent Shareholder Returns: The company trades at a compelling valuation (P/E of 9.7x, P/B of 1.03x) compared to its peers. This is supported by a history of consistent dividend payments and a healthy payout ratio. Favorable Industry Dynamics vs. Modest Growth: While the Indian plastic furniture market is poised for strong growth driven by urbanization and rising incomes, the company has demonstrated relatively flat revenue growth in recent years, highlighting a potential gap between market opportunity and execution.

Brief Growth Ideas: Primer: Wim Plast Ltd (WMP IN) - Nov 2025 and more

In this briefing: Primer: Wim Plast Ltd (WMP IN) - Nov 2025 Primer: Advanced Enzyme Technologies (ADVENZY IN) - Nov 2025 Primer: Mars Group Holdings (6419 JP) - Nov 2025 Sold Out Yet Stockpiled: Nvidia’s Q3 Highlights Potential Deployment Limits Bharti Airtel Block - Third Selldown by Promoter Entity This Year 1. Primer: Wim Plast Ltd (WMP IN) - Nov 2025 Strong Brand Equity and Distribution Network: Wim Plast leverages the widely recognized "Cello"brand, a household name in India for decades, coupled with a robust pan-India network of manufacturing units and depots, providing a significant competitive advantage. Attractive Valuation with Consistent Shareholder Returns: The company trades at a compelling valuation (P/E of 9.7x, P/B of 1.03x) compared to its peers. This is supported by a history of consistent dividend payments and a healthy payout ratio. Favorable Industry Dynamics vs. Modest Growth: While the Indian plastic furniture market is poised for strong growth driven by urbanization and rising incomes, the company has demonstrated relatively flat revenue growth in recent years, highlighting a potential gap between market opportunity and execution.

Advanced Enzyme Technologies Ltd. engages in the research, development, manufacture, and sale of enzyme products. It offers products for human nutrition, animal nutrition, food processing, and non-food processing. The company was founded by Chandrakant Laxminarayan Rathi on March 15, 1989 and is headquartered in Thane, India.

Current Price	267.00
Prev Close	266.40
Open	268.00
Dividend Yield	0.53%
50-Day Moving Average	295.45
Beta	-0.03
Avg. Volume	213,307.19
PE Ratio	18.03

52-Week High	419.00
52-Week Low	251.95
Market Capitalization	29.67B
EPS (Annual)	15.08
Price to Book	1.83
Revenue Per Employee	9.78M

Feed

News

Sentiment

Fundamentals

Info

ADVENZYMES.NSE Fundamentals